Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content
Poised to address unmet need in neuromuscular diseases and
positioned for growth

SEC Filing

SEC Filing Details

Document Details

Filing Date
May 6, 2026
Document Date
May 6, 2026
Form Description
SCHEDULE 13G - Description
Filing Group
Other
Company
Dyne Therapeutics, Inc.
Issuer
DYNE THERAPEUTICS, INC.